UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13D

This filing amends Schedule 13D filed October 6, 2000 (the “Original Filing”), regarding the common stock, $.0001 par value (the “Common Stock”), of Learning Tree International, Inc., a Delaware corporation (the “Company”), as amended by Schedule 13D/A filed February 20, 2003 (“Amendment 1”), as amended by Schedule 13D/A filed February 8, 2005 (“Amendment 2”), as amended by Schedule 13D/A filed October 16, 2006 (“Amendment 3”), as amended by Schedule 13D/A filed September 14, 2012  (“Amendment 4”), as amended by Schedule 13D/A filed December 28, 2012 (“Amendment 5”), as amended by Schedule 13D/A filed January 31, 2013 (“Amendment 6”), and as further amended by Schedule 13D/A filed February 25, 2013 (“Amendment 7” and, collectively, with the Original Filing, Amendment 1, Amendment 2, Amendment 3, Amendment  4, Amendment 5, and Amendment 6, the “Prior Filings”).  The Prior Filings are hereby amended as set forth below.  References should be made to the Prior Filings for additional information.  Terms with initial capital letters not defined in this Amendment No. 8 are used with the meanings assigned to them in the Prior Filings.

Item 4.

Purpose of Transaction

Item 4 is hereby amended and supplemented by adding the following:

On December 27, 2012, Dr. David C. Collins submitted to the Company a Notice of Nomination of Directors for the 2013 Annual Meeting, nominating each of Dr. David C. Collins, Eric R. Garen, and Dr. Henri Hodara (the “Nominees”) for election to the Board as Class III directors at the 2013 Annual Meeting and requesting that the Nominating Committee consider naming each of them to the Company’s slate of director nominees to be elected at the 2013 Annual Meeting. Dr. Collins has been informed that the Nominees have been selected as the Company’s Class III director nominees.

Also on December 27, 2012, Dr. Collins submitted a Notice of New Stockholder Business for the 2013 Annual Meeting (the “Notice of New Stockholder Business”) notifying the Company of his intent to bring before the 2013 Annual Meeting certain resolutions for approval and adoption by the stockholders of the Company. The proposed resolutions provided that stockholders would (i) amend the Company’s Bylaws to permit stockholders beneficially owning at least 20% in amount of the entire capital stock of the Company issued and outstanding, and entitled to vote, to call special meetings of the Company’s stockholders; (ii) repeal any non-stockholder approved provision of the Company’s Bylaws in effect at the time of the 2013 Annual Meeting that was not included in the Company’s Bylaws as publicly filed with the Securities and Exchange Commission prior to December 21, 2012; and (iii) request that the Board facilitate the declassification of the Board.

On February 25, 2013, the Board adopted an amendment to Article II, Section 3 of the Company’s Bylaws to permit stockholders who, individually or collectively, own at least 20% of all issued and outstanding shares of common stock of the Company to call a special meeting of stockholders (the “Amendment”). The Amendment became immediately effective on February 25, 2013. The Board also indicated to Dr. Collins that it would review the  possible declassification of the Board and consider it at a later date.

Accordingly, Dr. Collins has withdrawn the proposals contained in the Notice of New Stockholder Business.

Except to the extent that the foregoing may be deemed to be a plan or proposal, none of the Reporting Persons currently have any plans or proposals that relate to or would result in any of the actions specified in clauses (a) through (j) of Item 4 of Schedule 13D. Depending upon the foregoing factors and to the extent deemed advisable in light of their general investment policies, or other factors, the Reporting Persons may, at any time and from time to time, formulate other purposes, plans or proposals regarding the Company or the Common Stock, or any other actions that could involve one or more of the types of transactions or have one or more of the results described in paragraphs (a) through (j) of Item 4 of Schedule 13D. The foregoing is subject to change at any time, and there can be no assurance that any of the Reporting Persons will take any of the actions set forth above.

February 27, 2013

/s/ David C. Collins

David C. Collins

/s/ Mary C. Collins

Mary C. Collins

DCMA HOLDINGS, L.P.

By

/s/ Mary C. Collins

Mary C. Collins

Its General Partner

THE ADVENTURES IN LEARNING FOUNDATION

By

/s/ David C. Collins

David C. Collins

Its Trustee

THE COLLINS FAMILY FOUNDATION

By

/s/ Mary C. Collins

Mary C. Collins

Its President